Bioprocess Containers Market size is valued at USD 2,863.7 million in 2021 and is expected to grow at a significant CAGR of 11.8% during the forecast period 2022 to 2028. The global market provides a detailed overview and that can be segmented By Product Type, Application, and end-user. By product type, the bioprocess containers market has been segmented into 2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers & Accessories. the 2d bioprocess containers segment is likely to be the largest and fastest-growing segment in terms of type. Based on the application bioprocess container market is segmented into Process development, Upstream and Downstream Process. Among these, the Process development segment is expected to have the fastest-growing market during the forecast period 2022-2028 according to Precision Business Insights.
In May 2017, Merck opened its first joint bioprocess Scale-Up laboratory in Bengaluru, India with Stelis Biopharma to provide end-to-end solutions for pre-clinical, clinical and commercial supply indicating huge growth for the market in the region.
In April 2022, Thermo Fisher Scientific opened a single-use technology manufacturing site in Ogden, Utah which creates additional capacity to produce the high-quality technology and materials needed for the development of new vaccines and breakthrough therapies, thereby indicating the increased production of bioprocess containers.